Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Meiji Paints Consortium Plan of Its Own, Woos Generic Peers to Join Scheme
July 16, 2024
- Shonan iPark Commences Full-Fledged Operations in South Korea
July 16, 2024
- Ex-Teva Takeda Chief Matsumori to Lead Daito
July 16, 2024
- AbbVie Files Venclexta for Mantle Cell Lymphoma in Japan
July 16, 2024
- FDA Snubs MEDRx/DWTI’s Lidocaine Patch Yet Again
July 16, 2024
- Japan CGP Market Projected at 54 Billion Yen by 2035: Fuji Keizai
July 16, 2024
- Meiji Looks at Sales of 274 Billion Yen from Pharma Biz in FY2026
July 12, 2024
- Leqembi Approved in Hong Kong, Israel: Eisai
July 12, 2024
- Chiesi Joins Japan Rare Disease Market, Shoots for 10 Billion Yen Sales by 2030
July 12, 2024
- FY2023 Logs Gyration in COVID Drug Sales, Stark Contrast for Ronapreve, Lagevrio
July 11, 2024
- Taiho Bags Japan, Asian Rights to Arcus’ CD73 Inhibitor
July 10, 2024
- Mitsubishi Tanabe to Copromote Moderna’s mRNA Respiratory Vaccines
July 10, 2024
- Mounjaro Winner in May GP Rep Promotion Rankings: Intage
July 9, 2024
- Moderna Medical Chief Voices Excitement for Flu-COVID Jab; Japan PIII Set to Kick Off by Year’s End
July 9, 2024
- Shionogi Rolls Out In Vitro Diagnostic for Fetroja in Japan
July 9, 2024
- Rapalimus Granules Now Available in Japan: Nobelpharma
July 9, 2024
- FunPep to Run Additional Trial for Functional Peptide in Skin Ulcers
July 8, 2024
- Japan Ethical Drug Sales Up 4.9% in May: Crecon
July 8, 2024
- Viatris Begins Japan PIII for IgA Nephropathy Drug
July 5, 2024
- Keytruda Best-Selling Drug in Japan for 9 Months Running: Encise
July 5, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…